Strong patient demand and expanding trial sites are helping Paradigm progress its long-awaited phase III knee OA study.
Backed by government and industry partners, Micro-X is pushing its cold-cathode X-ray tech toward commercial readiness.
Rare earths and mineral sands hopeful Ark Mines wants to ride a wave of government support to production as soon as 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback